For: | Zhang J, Liu MH, Gao X, Dong C, Li YX. Vedolizumab-associated diffuse interstitial lung disease in patients with ulcerative colitis: A case report. World J Clin Cases 2022; 10(5): 1716-1722 [PMID: 35211614 DOI: 10.12998/wjcc.v10.i5.1716] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i5/1716.htm |
Number | Citing Articles |
1 |
Carolina Aliai Micol Cavalli, Roberto Gabbiadini, Arianna Dal Buono, Alessandro Quadarella, Alessandro De Marco, Alessandro Repici, Cristina Bezzio, Edoardo Simonetta, Stefano Aliberti, Alessandro Armuzzi. Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections. Journal of Clinical Medicine 2023; 12(19): 6419 doi: 10.3390/jcm12196419
|
2 |
Yang Li, Xiao-meng Li, Hao-yu Duan, Kai-di Yang, Jun-feng Ye. Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1398652
|
3 |
Jing Wang, Lin Luo, Xingtao Zhao, Xinyan Xue, Li Liao, Ying Deng, Mengting Zhou, Cheng Peng, Yunxia Li. Forsythiae Fructuse extracts alleviates LPS-induced acute lung injury in mice by regulating PPAR-γ/RXR-α in lungs and colons. Journal of Ethnopharmacology 2022; 293: 115322 doi: 10.1016/j.jep.2022.115322
|
4 |
|